Skip to content
  • HOME
  • ABOUT

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    LEARN MORE ➔
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    The China Dependence Big Pharma Doesn’t Want Washington to See

    The China Dependence Big Pharma Doesn’t Want Washington to See

    January 14, 2026

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    The China Dependence Big Pharma Doesn’t Want Washington to See

    CPA Celebrates Member PAI Pharma’s Acquisition of Nivagen Pharmaceuticals

    CPA Warns Congress Against Extending Failed AGOA Program Ahead of House Vote

    Guest Opinion: Why a Market Access Charge Would Have Greater Benefits Than Tariffs

    MORE FROM THE NEWSROOM ➔
  • RESEARCH
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

U.S. Trade Deficit Declines with Help from Commodity Exports, But Remains High

Issues, Featured Home Page, Newsroom, Trade and TariffsBy Kenneth RapozaJuly 7, 2022Leave a comment

A strong dollar is likely to keep imports flowing for the time being, especially from the EU.

From BlackRock to Washington Again: Biden Adds Big China Fan to Foreign Policy Board

Archive, CPA News, Featured Home Page, NewsroomBy Kenneth RapozaJuly 1, 2022Leave a comment

Tom Donilon, Chairman of the BlackRock Investment Institute, and a China bull, returns to Washington as co-chair of Foreign Affairs Policy Board.

American Manufacturers’ Share of U.S. Market Hits New Low

Archive, commentary, Commentary Featured, Featured Home Page, Issues, Manufacturing, NewsroomBy Kenneth RapozaJune 28, 2022Leave a comment

A new index measures the amount of manufactured goods consumed in the U.S. that are made here opposed to imported.

Will China Products be Banned from U.S. Military Bases?

Archive, China, CPA News, Featured Home Page, Issues, Newsroom, Supply ChainBy Kenneth RapozaJune 24, 2022Leave a comment

The House Armed Services Committee passed its version of the National Defense Authorization Act this week, with many amendments taking swipes at China reliance.

Katherine Tai Defends Section 301 China Tariffs in Senate Hearing

Archive, CPA News, Featured Home Page, Issues, Newsroom, Trade and TariffsBy Kenneth RapozaJune 23, 2022Leave a comment

In one of her best hearings yet, USTR Katherine Tai holds fast on why the U.S. needs the Section 301 tariffs on China.

China Solar Stocks Rise by 10%-Plus After Not Making Forced Labor List

Featured Home Page, Commentary Featured, CPA News, Issues, Newsroom, Renewable EnergyBy Kenneth RapozaJune 21, 2022Leave a comment

Homeland Security’s report to Congress on June 17 calls out Xinjiang Daqo New Energy, but leaves out its Shanghai operation listed on the NYSE.

What We Learned from the Latest China Hearing in Washington

Archive, China, CPA News, Featured Home Page, Issues, NewsroomBy Kenneth RapozaJune 17, 2022Leave a comment

The latest Congressional-Executive Commission on China heard from a State and Homeland official on China’s surveillance abroad. What can be done?

FDA Advancements Act Passes Committee, Sets Stage for Fall Reauthorization Passage

Archive, CPA News, Featured Home Page, Healthcare, Issues, Manufacturing, NewsroomBy Kenneth RapozaJune 15, 2022Leave a comment

The FDA Safety and Landmark Advancements (FDASLA) Act has passed a key committee, with 25 out of some 30 amendments passing. Generics and baby formula crisis got most of the attention.

Harry Moser: Is the U.S. Succeeding at Reshoring?

Archive, commentary, Commentary Featured, Featured Home Page, Issues, Manufacturing, Newsroom, Supply ChainBy Kenneth RapozaJune 14, 2022Leave a comment

Harry Moser of the Reshoring Initiative gives his assessment of America’s reshoring efforts in testimony to the U.S. China Economic and Security Review Commission.

Defense Official Makes Case Against Biden’s Anti-American Solar Policy

Archive, China, CPA News, Featured Home Page, Issues, Manufacturing, Newsroom, Renewable Energy, Supply ChainBy Kenneth RapozaJune 13, 2022Leave a comment

Deborah Rosenblum of the Department of Defense tells the U.S. China Economic and Security Review Commission that Washington has to reshore critical supply chains.

←1
2345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061
…6263646566…
676869707172737475767778798081828384858687888990919293949596979899
100→
  • ABOUT
  • NEWSROOM
  • MEMBERSHIP
  • CONTACT
Facebook-f Youtube Linkedin

© 2025 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • STAFF
    • BOARD
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • RESEARCH
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Twitter
 Facebook
 LinkedIn
 Copy

Share on Mastodon